CFM
WST icon

Catalyst Funds Management’s West Pharmaceutical WST Stock Holding History

Catalyst Funds Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$681K Buy
+1,897
New +$580K 0.04% 346
2026
Q1 		– Sell
-1,440
Closed -$396K – 725
2025
Q4 		$396K Buy
+1,440
New +$394K 0.09% 202
2024
Q3 		– Sell
-100
Closed -$32.9K – 1630
2024
Q2 		$32.9K Buy
+100
New +$35.3K 0.01% 532

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Catalyst Funds Management's WST Position: Q2 2026 in Review

Catalyst Funds Management opened a new position in West Pharmaceutical (WST) in Q2 2026: 1,897 shares worth $681K. The stake represents 0.04% of the portfolio and ranks #346 among its holdings. This is a return to the name: Catalyst Funds Management previously reported a position in WST as recently as Q4 2025.

Catalyst Funds Management first reported a position in WST in Q2 2024 and has held it in 3 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Catalyst Funds Management held 1,897 shares of West Pharmaceutical worth $681K as of Q2 2026.
  • West Pharmaceutical was a new Catalyst Funds Management position in Q2 2026.
  • West Pharmaceutical made up 0.04% of Catalyst Funds Management's portfolio in Q2 2026, its #346 holding.
  • Catalyst Funds Management first reported a position in West Pharmaceutical in Q2 2024 and has held it in 3 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.